Announcement

Collapse
No announcement yet.

MAIN PAGE: Post-Gillette: Will the life sciences pick up the slack?

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • MAIN PAGE: Post-Gillette: Will the life sciences pick up the slack?

    Post-Gillette: Will the life sciences pick up the
    slack?

    EXCLUSIVE REPORTS

    Boston Business Journal (Boston, MA)
    February 4, 2005

    By Mark Hollmer, Journal Staff

    While the Boston region risks losing more than a
    thousand jobs following the sale of the venerable
    Gillette Co. to Procter & Gamble Co., the state's
    health care and life sciences sectors offer a partial
    silver lining.

    Some of the region's major hospitals and biotechnology
    companies plan to add or fill nearly 2,700 combined
    jobs over the coming year, based on informal Boston
    Business Journal estimates.

    Some insiders say the net job growth will at least
    lessen the pain generated by Gillette's loss and the
    region's recent financial services consolidations,
    revealing that health care and life sciences are
    rising to the task.

    "It is ... a consciousness-raising event, that
    presents ... opportunities for all of us leaders in
    the business community and leaders in the public arena
    to become specifically focused on the opportunities
    that present themselves in and around biotechnology,
    specifically, and life sciences in general," said
    Thomas Finneran, the new president of the
    Massachusetts Biotechnology Council and former
    longtime House speaker.

    Others point out that jobs gains in health and life
    sciences, however welcome, don't diminish the fact
    that executives and employees of a consumer-products
    company such as Gillette can't necessarily transfer
    their skills to the new sectors posting "help wanted"
    signs.

    "What happens to the 1,800 people in the (Gillette)
    executive office? They're probably not going to move
    into positions created in health care/life sciences,"
    said Richard Lord, president and CEO of Associated
    Industries of Massachusetts.

    With the New England Economic Project projecting the
    creation of 43,000 jobs in Massachusetts through 2005,
    many of those jobs could come from life sciences and
    health care. However, many of those jobs will be
    focused on research and development and won't likely
    lead to many local manufacturing jobs here, said
    Noubar Afeyan, managing partner at Flagship Ventures
    in Cambridge and a senior lecturer at the
    Massachusetts Institute of Technology's Sloan School
    of Management.

    Genzyme Corp. in Cambridge, which employs 4,990 people
    in Massachusetts, said in December that it had 300
    regional job openings and plans to fill between 300
    and 500 new and vacant positions. The Novartis
    Institutes for BioMedical Research Inc., which brought
    900 jobs to Cambridge last year, plans to add about
    200 more in 2005. Boston Scientific Corp. in Natick
    employs 2,073 people in Massachusetts and added 384
    people regionally in 2004. The medical device giant
    plans to fill 183 positions here in 2005 and
    potentially more, according to a spokesperson.

    Even such smaller companies as Transkaryotic Therapies
    Inc. in Cambridge, which employs 380 people, hired 60
    people in 2004. TKT will hire 20 more through the
    first part of this year as it focuses on gaining
    regulatory approvals for two of its compounds.
    AstraZeneca, which employs 1,203 people at its Waltham
    research facility, also plans to hire locally this
    year for sales, research and development and
    operations positions.

    Massachusetts General Hospital said in December it
    would add 725 clinical care and research jobs to its
    18,127-person work force in 2005. Beth Israel
    Deaconess Medical Center said it plans to add 350
    clinical care employees to its 6,700-person work
    force, and Children's Hospital Boston said it would
    boost its 7,200-person staff over the next year by 250
    people. Brigham and Women's Hospital is aiming to fill
    at least 120 vacant nursing positions alone.

    Biopharmaceutical employment in Massachusetts reached
    21,400 people in 2003 and will continue to grow as the
    industry expands, according to the Milken Institute,
    which recently compiled a report looking at
    biopharmaceutical industry contributions domestically.

    Health care employment in Massachusetts varies by
    sector, but hospitals show the most growth. Hospitals
    employed 156,100 people in December 2003, and the
    number jumped by 1,500 by December 2004, according to
    data from the state Division of Unemployment Career
    Services.


    Mark Hollmer can be reached at
    [email protected]

    http://www.bizjournals.com/boston/stories/2005/02/07/story4.html
Working...
X